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Abstract 0 Percutaneous absorption of topically applied mannitol and
progesterone was compared in vivo with the hairless and hairy rat. Urinary
excretion and skin concentration profiles after topical application of mannitol
demonstrated that hairless rat skin was a “leakier” barrier to percutaneous
absorption of polar compounds than was hairy rat skin, independent of
formulation. Liposomal, but not aqueous mannitol was retained in hairy
rat skin (> 0.5% after 12 h), whereas only negligible amounts were retained
in hairless rat skin, regardless of formulation. Progesterone absorption
from hydroalcohol and liposomal formulations into hairless rat skin was
about five times greater than that in hairy rat skin. Skin delipidization by
acetone resulted in a dramatic reduction in the cutaneous barrier to
systemic mannitol absorption, which was much more pronounced in hairy
than in hairless rat skin. Histological findings of patulous cysts and
enlarged, highly vascularized sebaceous glands in the hairless rat
suggested that these structures may enhance polar pathways and provide
a lipophilic reservoir relative to the fully developed hair follicles of the
hairy rat. Collectively, the results document percutaneous absorption
differences as a function of animal model, and also suggest that follicular
structures make a major contribution to passive percutaneous absorption.
Introduction
The stratum corneum has been described previously as a
heterogeneous, dual-natured lipid-keratin matrix, consisting
of parallel polar and lipoidal pathways.1-3 Besides constitut-
ing the major barrier to permeation through the skin, the
stratum corneum is also a major pathway for penetration of
compounds.4-6 The lipid lamellae of the stratum corneum
severely restrict penetration of hydrophilic compounds to a
remarkably larger degree than that of lipophilic compounds.5
Efficient delivery of hydrophilic compounds is dependent on
vehicle formulation, which may preferentially enhance specific
pathways.2 The stratum corneum favors the transport of
lipophilic compounds,5 so it is not surprising that most topical
studies have focused on characterizing transport routes for
nonpolar, rather than polar drug molecules. Therapeutic
applications of peptides and proteins in topical drug delivery
have yet to be fully realized.7 Optimal utilization of these
exciting new resources will necessitate further characteriza-
tion of polar routes and development of vehicles to enhance
hydrophilic drug delivery.
In addition to the lipid bilayers of the stratum corneum,
hair follicles and sebaceous glands have been recognized
increasingly as significant routes for penetration of compounds
into the skin.7 Although hair follicle openings occupy only
∼0.1% of the human skin surface area,8 they are continuous
with the viable epidermis, which displays less resistance to
polar drug diffusion than does the stratum corneum.5 Local-
ized drug delivery to the hair follicle may be a feasible
approach to treating several dermatological diseases involving
the hair follicle, including acne, rosacea, alopecia areata, and
baldness.
Early studies of the follicular pathway were based on the
hypothesis that the hair follicle acts as a shunt, resulting in
the transport of polar drugs that would not ordinarily be
expected to readily traverse the lipid matrix of the stratum
corneum.9 More recent studies have focused on the possibility
of the pilosebaceous unit acting as a drug reservoir for
compounds with varying physicochemical characteristics.10-13
Sebum, which flows into the hair follicle from the sebaceous
duct, may necessitate a certain degree of lipophilicity for
compounds to enter the hair follicle.14 Consistent with this
concept, topical liposomal formulations localize delivery of
carboxyfluorescein and R-interferon into sebaceous glands
associated with hair follicles.15 Interestingly, these studies
found that liposomes combined with free drug solution
enhance delivery, whereas entrapment may actually hinder
the drug delivery process.
The primary difficulty in elucidating the follicular pathway
has been the lack of an adequate animal model. Hairless
rodents, which are used commonly in percutaneous absorption
studies, are not follicle-free. Furthermore, the stratum cor-
neum of hairless rodent skin is typically hyperkeratinized,
pilosebaceous units (hair follicles and sebaceous glands) are
enlarged, and cysts frequently are present in the epidermis,
dermis, and hair follicles.16,17 These aberrations are also
present in the CRL CD hairless rat, which is sometimes
described as a “fuzzy” rat because of its sparse, short, broken
hairs.18 Fuzzy mutants are phenotypically different than their
normal siblings in that they have curled vibrissae at birth
and a sparse pelage of broken hairs, which after 10 to 15 days
may appear slightly fuzzy. Unlike most genetically hairless
rodents, this hairless rat strain never develops a wavy coat
that rapidly loses hair. Morimoto and co-workers19 compared
in vitro percutaneous absorption properties of a hairless rat
strain and human skin with a wide range of drugs of differing
lipophilicities.19 Permeability of lipophilic drugs was slightly
higher in human skin, whereas permeability of hydrophilic
drugs was remarkably higher in hairless rat skin. The
contrasting results were attributed to species-specific differ-
ences in lipid content and water uptake in the stratum
corneum. Hueber and co-workers20 concluded that deposition
of lipophilic steroids into hairless rat skin was exaggerated
due to the presence of numerous hair follicles and sebaceous
glands.20 The authors21 reported that a scarred-skin hairless
rat model,21 devoid of hair follicles and sebaceous glands,X Abstract published in Advance ACS Abstracts, December 15, 1996.
© 1997, American Chemical Society and S0022-3549(96)00350-4 CCC: $14.00 Journal of Pharmaceutical Sciences / 13
American Pharmaceutical Association Vol. 86, No. 1, January 1997
+ +
provided a reduced depot for lipophilic steroids compared with
that provided by intact hairless rat skin. Despite the known
aberrations in skin structure and increasing reports of erratic,
exaggerated permeability profiles, hairless rodents continue
to be popular models that are valued for convenience in
dermatological studies.
In these studies, we have investigated mannitol transport
in the CRL CD hairless rat and Sprague-Dawley hairy rat
upon topical application of aqueous, hydroalcoholic, and
liposomal preparations. Mannitol was chosen as the hydro-
philic test penetrant because it is a simple, nonmetabolizable,
nonionic, and extremely polar molecule. Percutaneous ab-
sorption of a highly lipophilic molecule, progesterone, was also
examined as an extreme comparison to mannitol deposition.
In addition, mannitol and progesterone transport profiles were
compared in both rat species after acetone stripping the skin
to achieve stratum corneum delipidization. Histological dif-
ferences in untreated hairless and hairy rat skin, as examined
by light microscopy, are also presented. These results indicate
that substantial differences in absorption profiles exist be-
tween hairless and hairy rats, and suggest that follicular
structures are major determinants of cutaneous permeability
and absorptive capacity.
Materials and Methods
MaterialssD-Mannitol, progesterone, and the buffer salt [HEPES
((4-hydroxyethyl)piperazine-N′-(4-ethanesulfonic acid))] were pur-
chased from Sigma Chemical Company (St. Louis, MO). The unla-
beled drug solutions were combined during the formulation process
with trace amounts of >99% pure [14C]D-mannitol or [3H]progesterone,
which were purchased from NEN (Boston, MA). High purity (> 99
%) egg phosphatidylcholine (PC) and brain phosphatidylserine (PS)
were purchased from Avanti Polar Lipids, Inc. (Birmingham, AL).
About 0.1 mol % d-R-tocopherol, which was purchased from Eastman
Kodak (Rochester, NY), was added during phospholipid liposome
preparation to prevent lipid oxidation. Glyceryl dilaurate (GDL),
cholesterol (CH), and polyoxyethylene-10-stearyl ether (POE) were
supplied by IGI (Little Falls, NJ). All solvents used were of analytical
grade. Ecolite scintillation cocktail was purchased from ICN (Costa
Mesa, CA). Male, 6-8-weeks-old CRL CD hairless rats and Sprague-
Dawley hairy rats were purchased from Charles River Laboratories
(Wilmington, MA).
Preparation of FormulationssAqueous solutions containing
mannitol were prepared using isotonic HEPES buffer (pH 7.4).
Hydroalcoholic solutions were prepared with 60% ethanol (v/v) and
mannitol or progesterone, each at 2.5 mg/mL. Phospholipid liposomes
comprising PC, CH, and PS at a mole ratio of 1.0: 0.5: 0.1, were
prepared by a conventional film technique as reported by Kirby and
Gregoriadis.22 Nonionic liposomes comprising GDL, CH, and POE
were prepared by a syringe technique at a weight ratio of 58: 15:
27, as previously described.15 “Empty” liposomes were prepared, to
which an equal volume of aqueous mannitol solution was added,
resulting in a liposome dispersion surrounded by free mannitol in
solution. For preparation of progesterone-containing liposomes,
radiolabeled and unlabeled progesterone were incorporated into the
lipid phase during liposome production to allow for drug intercalation
into liposomal bilayers. All liposome formulations contained a final
lipid concentration of 50 mg/mL with either mannitol at 2.5 mg/mL
or progesterone at 100 µg/mL.
Deposition StudiessAfter anesthetizing hairless and hairy rats
with sodium pentobarbital in saline (40 mg/kg), 100 µL of formulation
was applied to a 4.84-cm2 dorsal skin site. Hairy rat skin was clipped
carefully with an electric clipper 24 h prior to applying the formula-
tion. Anesthesia was maintained as necessary for the duration of
the study. The rats were euthanized at various time points, after
which the skin, heart, liver, and kidneys were excised. Hairless rat
skin was stripped until a shiny appearance was attained (25 to 30
times), indicating total removal of stratum corneum. The “upper”
stratum corneum was defined as tape strips 4-10 (strips 1-3 were
excluded due to their retention of drug formulation on the skin
surface), whereas the “deeper” stratum corneum was defined as tape
strips 11-25. The skin remaining after stripping was designated the
“viable skin,” consisting of epidermis and dermis. The viable skin
was swabbed of excess formulation with a slightly dampened Kim-
Wipe. Individual tape strips and viable skin were analyzed for
radiolabel by liquid scintillation counting. Hairy rat skin was stripped
with heavy-duty clear packaging tape to ensure total removal of hair.
Tape strips from hairy rat skin were not assayed because the strips
would not distinguish between deposition into stratum corneum and
onto the hair shafts remaining post-clipping. As with hairless skin,
the residual skin after tape stripping was regarded as the “viable
skin.” Urine was collected during and upon termination of the study
and analyzed by liquid scintillation counting for radiolabel (Beckman
LS 6000). Organs were either oxidatively combusted in a tissue
oxidizer (Packard Instruments, Downers Grove, IL) followed by liquid
scintillation counting of the resulting condensate, or subjected to
extraction by ethanol soaking followed by liquid scintillation counting
of the filtered solution. Results were calculated as a percentage of
the applied dose, and statistical analysis was performed with Systat
software using a two-tailed Student’s t test.
Histological StudiessHairless and hairy rats were euthanized,
followed by excision of 4 cm2 dorsal skin sites from each rat. After
fixing freshly excised skin in buffered 10% formalin solution, the
specimens were embedded in paraffin and vertically sectioned at 5
µm. Sections were hematoxylin- and eosin-stained and examined by
light microscopy and photomicrography.
Acetone-Stripping StudiessHairless and hairy rats were anes-
thetized as already indicated, and then received a direct application
of 500 µL of acetone in 250-µL aliquots by pipette to a 5-cm2 dorsal
site on each rat. Following this application, a total of 3 mL of acetone
was applied with soaked Kim-Wipe swabs, and gently rubbed into
the skin over ∼10 min. A site measuring 4.84 cm2 was outlined in
the acetone treated area, followed by application of 100 µL of 60%
ethanol in water (v/v), containing progesterone (2.5 mg/mL) or
mannitol (2.5 mg/mL). After 6 h, the rats were euthanized, the
treated skin site was excised, and a laparotomy was performed to
remove urine, liver, and blood. The skin was tape-stripped of stratum
corneum until shiny and no hairs remained. Viable skin, stratum
corneum tape strips, urine, plasma, and liver filtrate were assayed
for radiolabel by liquid scintillation counting.
Results
Deposition StudiessRegardless of formulation and time
of sampling, accumulation of radiolabeled mannitol in the
urine after topical application was significantly higher in
hairless rats than in hairy rats (p ) 0.001). As shown in
Figure 1, urinary levels of radiolabel in hairless rats ap-
proached 1% after 12 h, whereas urinary levels in hairy rats
were always < 0.05%. Conversely, >0.5% of liposomal man-
nitol was found in the living skin strata of the hairy rat after
12 h, whereas < 0.1% of the applied dose was found in the
living skin strata of the hairless rat, regardless of formulation
(Figure 2). Aqueous solutions resulted in minimal skin
deposition in both strains, whereas nonionic and phospholipid
liposomal formulations yielded significantly enhanced deposi-
tion profiles in hairy rat skin at all time points tested (p )
0.001). Mannitol deposition from phospholipid liposomes was
slightly greater than that achieved by nonionic liposomes (p
) 0.03). Formulation effects on mannitol deposition into
hairless rat stratum corneum are shown in Figure 3. After 3
h, no differences were noted among formulations, whereas at
later time points, nonionic liposomes and hydroalcoholic
solutions were superior to aqueous (p < 0.02) and phospholipid
liposomes (p < 0.03) in depositing mannitol into the stratum
corneum. Although both strains exhibited nearly the same
degree of mannitol deposition into the viable skin (i.e.,∼0.15%
for both), strikingly greater systemic transport was observed
in the hairless rat following topical application of hydroalco-
holic solutions (> 1.5% versus 0.1% for hairy rats, p ) 0.004;
Figure 4). Regardless of formulation or species, negligible
mannitol levels were found in the blood and liver.
After 12 h, distinct differences were also found in proges-
terone deposition in the viable skin of hairless and hairy rats
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(Figure 5). For all formulations, deposition was significantly
greater in hairless rat skin (p < 0.02), ultimately attaining
∼5-6% of the applied dose. As observed for mannitol,
systemic transport of progesterone was also significantly
greater in hairless rat whether formulated in phospholipid
liposomes (p < 0.01), nonionic liposomes (p < 0.02), or
hydroalcoholic solution (p < 0.01). In comparing formulations
used on hairless rat skin (Figure 5a), it was found that the
hydroalcoholic solution allowed more efficient deposition into
viable skin than either liposome formulation (p < 0.01). In
hairless rats, urinary progesterone levels were nearly equiva-
lent (p >0.05), regardless of formulation. After 12 h, hydroal-
coholic deposition of progesterone into hairless rat stratum
corneum was ∼10% for both the upper and deeper layers,
whereas phospholipid and nonionic liposomes achieved ∼16-
17% and 8% in the upper and lower stratum corneum,
respectively (data not shown).
Histological StudiessLight microscopy revealed gross
histological differences between hairy and hairless rat skin.
As shown in Figure 6a, hairless rat skin displayed numerous,
enlarged sebaceous glands that appeared to be independent
of hair follicles, which were themselves atrophic. Numerous
cystic structures were present in the epidermis, some of which
appeared to be in communication with the skin surface. Many
of the enlarged sebaceous glands were filled with lamellated
keratin. In contrast, hairy rat skin displayed well-developed
hair follicles clearly associated with smaller sebaceous glands
located much deeper in the dermis (Figure 6b). No cysts were
apparent in hairy rat skin, and follicle-independent sebaceous
glands were observed only rarely, probably as an artifact of
sectioning.
Figure 1sUrinary deposition of mannitol. In vivo deposition of mannitol after topical
application of (stippled dots) aqueous solution, (diagonal lines) phospholipid
liposomes, or (solid) nonionic liposomes to (a) hairless rat skin and (b) hairy rat
skin (n ) 3−6, mean ± SEM).
Figure 2sViable skin deposition of mannitol. In vivo deposition of mannitol after
topical application of (stippled dots) aqueous solution, (diagonal lines) phospholipid
liposomes, or (solid) nonionic liposomes of mannitol to (a) hairless rat skin and
(b) hairy rat skin (n ) 3−6, mean ± SEM).
Figure 3sHairless rat stratum corneum, deposition of mannitol (12 h). In vivo
deposition of mannitol into hairless rat stratum corneum (SC) after 12-h topical
application of (stippled dots) aqueous solution, (diagonal lines) phospholipid
liposomes, (solid) nonionic liposomes, or (horizontal lines) hydroalcoholic solution
(n ) 3−6, mean ± SEM).
Figure 4sEffect of hydroalcoholic solution (12 h). In vivo deposition of mannitol
into (open) hairless rat and (hatch marks) hairy rat urine and skin after 12-h
topical application of 60% ethanol in water (v/v; n ) 3, mean ± SEM).
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Acetone-Stripping StudiessA 6-h topical application of
mannitol after acetone-stripping (Figure 7a) resulted in a
remarkable enhancement of systemic mannitol transport
(>30% of the applied dose) through hairy rat skin as compared
with hairless rat skin (p < 0.002). Mannitol was not detected
in the liver or blood, and deposition into the viable skin was
∼1.6% for each species. In contrast, acetone-stripping of hairy
rat skin resulted in higher levels of progesterone in the urine
(p < 0.005) and liver (p < 0.05; Figure 7b). As observed
without stripping, progesterone deposition was significantly
lower in hairy rat skin than in hairless rat skin (p < 0.005).
Discussion
Hairless rat skin was far more permeable than hairy rat
skin to both progesterone and mannitol, regardless of formu-
lation (Figures 1 and 2). Collectively, the data suggest that
strain differences in skin structure and composition may
explain these observations. Our findings of substantial
systemic mannitol transport in hairless rat skin failed to
match results of past studies of mannitol transport in human
skin that indicated a much lower permeability.23,24 Hairy rat
skin provided a more efficient barrier that largely prohibited
mannitol transport into and through the skin, provided that
an enhancer system was not present (Figures 1b and 2b).
These results appear to more closely reflect the human
data23,24 probably because they more closely replicate the
human experimental condition than do most previous studies
that have been conducted ex vivo and in the presence of
organic solvents.
Deposition of mannitol in appreciable amounts into the
viable skin of hairy rats occurred only upon topical application
of liposome formulations (Figure 2b), suggesting that lipo-
somes preferentially enhance mannitol deposition into hairy
rat stratum corneum and eventually into viable skin. Alter-
natively, fully developed hair follicles of the hairy rat may
represent drug depots for liposome-associated mannitol. The
greater deposition of mannitol from phospholipid liposomes
was somewhat surprising, as phospholipids only minimally
perturb the stratum corneum and therefore possess little
intrinsic permeation enhancement activity via this mecha-
nism.25 These results would be consistent with a follicular
mechanism for delivery, as permeation enhancement effects
are generally thought to be mediated via perturbation of the
interfollicular stratum corneum.7
The major differences in mannitol deposition among for-
mulations were found in hairless rat stratum corneum (Figure
3). Given the known permeability enhancement effects of
nonionic liposome components26 and ethanol,24,27 these results
are not unexpected. Upon dehydration, GDL melts (mp ) 30
°C), which may facilitate the release of POE from the
destabilized bilayers. As a result, both lipids may act
independently as enhancers. However, comparison of viable
epidermis values showed no differences in deposition among
the formulations, indicating that no gradient for transport
existed between the stratum corneum and the viable epider-
mis. The data suggest that upon traversing hairless rat
stratum corneum, mannitol was cleared very rapidly from the
epidermis and dermis into the systemic circulation. The
pharmacokinetics of mannitol, which is entirely renally
eliminated, have been described in human and canine studies
by Cloyd and co-workers.28 Following an intravenous bolus
dose of mannitol, the mean distribution half-life in humans
is <5 min, and the elimination half-life is between 1 and 1.5
h.
Figure 5sProgesterone deposition from liposomes and hydroalcoholic solution
(12 h). In vivo deposition of progesterone into viable skin, urine, and liver after
12-h topical application of (horizontal lines) hydroalcoholic solution, (diagonal lines)
phospholipid liposomes, or (lines) nonionic liposomes to (a) hairless rat skin or
(b) hairy rat skin (n ) 3−4, mean ± SEM).
Figure 6sLight microscopy photographs (100X) showing hematoxylin- and eosin-
stained 5-µm vertical skin sections of untreated (a) hairless rat skin and (b) hairy
rat skin.
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As shown in Figure 4, mannitol transport was enhanced
slightly in both hairy and hairless rat skin after a 12-h topical
application of a 60% hydroalcoholic solution. Short-chain
alcohols are known to increase skin permeability in a revers-
ible manner24,27 and are commonly used in topical prepara-
tions for this reason. Goates and co-workers24 found that
ethanol may reorganize or extract lipids and induce confor-
mational changes in the stratum corneum proteins, resulting
in a subtle enhancement of mannitol deposition into viable
human skin. However, hydroalcoholic solutions did not
deliver drug to viable hairy rat skin as efficiently as liposomal
dispersions. These results extend the aforementioned simi-
larities between normal human skin and hairy rat skin.
Like mannitol, progesterone also permeated hairless skin
more readily than hairy skin. However, the differences
between the two strains were less marked than those observed
for mannitol, suggesting the hypothesis that nonfollicular
pathways may predominate in the transport of lipophilic
compounds, whereas follicular pathways predominate for more
polar compounds. This hypothesis would be consistent with
the results shown in Figure 7, which demonstrate significant
differences in the behavior of these two compounds as a
function of acetone pretreatment.
Acetone has been used in several studies to delipidize the
stratum corneum,29-32 with the ultimate goal of assessing
barrier function and recovery. A single 10-min acetone
treatment results in profound impairment of barrier function,
with a rapid recovery phase (50% in 6 h) followed by a slow
recovery phase of 24 to 36 h. Acetone treatment followed by
application of progesterone in hydroalcoholic solution yielded
deposition profiles in both strains that were similar to those
obtained without acetone treatment. In contrast, application
of mannitol in hydroalcoholic solution yielded remarkably
different results, as a large increase in transport was observed
as a function of acetone pretreatment in both hairless and
hairy strains, with a remarkable 30% level of systemic
absorption in the hairless strain (Figure 7).
The contrasting transport profiles observed for both com-
pounds in hairless versus hairy rat skin may be explicable
by the gross differences in skin structure between the two
strains (Figure 6). The numerous enlarged and dilated cysts
and sebaceous glands of the hairless rat could provide a
significant pathway with particularly low resistance to trans-
port of polar compounds, effectively bypassing the normal
interfollicular stratum corneum as originally proposed in the
“shunt hypothesis” of Scheuplein and Blank.8,9 Considering
the rich vasculature surrounding the sebaceous glands,33 it
is not unreasonable to postulate that the exaggerated systemic
transport of mannitol observed in the hairless rat is occurring
via such a follicular shunt.
As a plausible explanation for the acetone pretreatment
results, consider the possibility that acetone pretreatment has
different effects on the permeability properties of the follicular
and interfollicular compartments. Thus, Imokawa and co-
workers31,32 found that removal of sebaceous gland lipids from
human skin plateaus after 1 min, whereas stratum corneum
lipids require much more prolonged acetone treatment to be
extracted.31,32 These results suggest that the stratum cor-
neum lipids are more difficult to extract than are the seba-
ceous gland lipids. Assuming that our brief acetone treatment
condition has similar effects on rat skin and that lipid content
is a significant determinant of permeability in both compart-
ments, then such a treatment would be expected to greatly
facilitate the absorption of mannitol by providing a more
hydrophilic compartment for mannitol transport. If, in con-
trast, progesterone undergoes absorption primarily via par-
titioning into stratum corneum lipids, then acetone pretreat-
ment would be expected to have little effect on progesterone
transport. This concept would be consistent not only with the
observed permeability results, but also with the visual
observation that acetone treatment has a much more promi-
nent visible effect on hairless, than on normal mouse skin
(data not shown). This hypothesis could be further tested, at
least indirectly, by making parallel measurements of perme-
ability, histology, and extracted lipid composition before and
after acetone stripping and after “refilling” stripped follicles
by application of sebaceous gland or other lipids prior to
application of mannitol versus progesterone.
Summary
A major obstacle in topical delivery studies continues to be
the selection of appropriate animal models. The studies
presented here emphasize some of the differences in absorp-
tion profiles that are animal model-dependent. These results
are likely explained by species-specific structural and com-
positional differences of the stratum corneum and piloseba-
ceous units, which are important considerations when using
animal models for skin permeability studies. Hairless rat skin
appears to be an exaggerated model for follicular delivery, but
nevertheless suggests that hair follicles and sebaceous glands
may play a greater role in topical drug delivery than previ-
ously assumed. Elucidation of the kinetics of follicular
delivery along with optimization of topical formulations are
necessary steps toward developing drug delivery systems that
target the pilosebaceous unit. The persistence of a vast array
of dermatological diseases associated with the pilosebaceous
unit hints at the potentially great therapeutic significance of
drug delivery to sites associated with this structure.
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